IRIS Accounts Production v23.3.1.45 06448822 director 1.1.23 31.12.23 31.12.23 Sale of medical equipment 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064488222022-12-31064488222023-12-31064488222023-01-012023-12-31064488222021-12-31064488222022-01-012022-12-31064488222022-12-3106448822ns10:Originalns15:EnglandWales2023-01-012023-12-3106448822ns14:PoundSterlingns10:Original2023-01-012023-12-3106448822ns10:Originalns10:Director12023-01-012023-12-3106448822ns10:Original2023-01-012023-12-3106448822ns10:Original2023-12-3106448822ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3106448822ns10:Originalns10:SmallEntities2023-01-012023-12-3106448822ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3106448822ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3106448822ns10:SmallCompaniesRegimeForAccountsns10:Original2023-01-012023-12-3106448822ns10:Originalns10:FullAccounts2023-01-012023-12-3106448822ns10:Originalns10:RegisteredOffice2023-01-012023-12-3106448822ns10:Original2022-01-012022-12-3106448822ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3106448822ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3106448822ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-12-3106448822ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3106448822ns10:Original2022-12-3106448822ns10:Originalns5:CurrentFinancialInstruments2023-12-3106448822ns10:Originalns5:CurrentFinancialInstruments2022-12-3106448822ns10:Originalns5:Non-currentFinancialInstruments2023-12-3106448822ns10:Originalns5:Non-currentFinancialInstruments2022-12-3106448822ns5:ShareCapitalns10:Original2023-12-3106448822ns5:ShareCapitalns10:Original2022-12-3106448822ns10:Originalns5:PlantMachinery2023-01-012023-12-3106448822ns10:Originalns5:PlantMachinery2022-12-3106448822ns10:Originalns5:PlantMachinery2023-12-3106448822ns10:Originalns5:PlantMachinery2022-12-3106448822ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3106448822ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 06448822 (England and Wales)















Report of the Director and

Unaudited Financial Statements for the Year Ended 31 December 2023

for

Mercado Medic UK Limited

Mercado Medic UK Limited (Registered number: 06448822)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Report of the Director 2

Statement of Income and Retained Earnings 3

Balance Sheet 4

Notes to the Financial Statements 6


Mercado Medic UK Limited

Company Information
for the Year Ended 31 December 2023







DIRECTOR: S Van Bloemendaal





REGISTERED OFFICE: Innovation Centre
Gallows Hill
Warwick
Warwickshire
CV34 6UW





REGISTERED NUMBER: 06448822 (England and Wales)






Mercado Medic UK Limited (Registered number: 06448822)

Report of the Director
for the Year Ended 31 December 2023

The director presents his report with the financial statements of the company for the year ended 31 December 2023.

DIRECTOR
S Van Bloemendaal held office during the whole of the period from 1 January 2023 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





S Van Bloemendaal - Director


29 February 2024

Mercado Medic UK Limited (Registered number: 06448822)

Statement of Income and Retained Earnings
for the Year Ended 31 December 2023

31.12.23 31.12.22
£    £   

TURNOVER 602,513 516,571

Cost of sales 348,663 266,828
GROSS PROFIT 253,850 249,743

Administrative expenses 160,124 116,298
OPERATING PROFIT 93,726 133,445

Interest receivable and similar
income

683

287
94,409 133,732

Interest payable and similar
expenses

23,016

26,561
PROFIT BEFORE TAXATION 71,393 107,171

Tax on profit 55 -
PROFIT FOR THE FINANCIAL YEAR 71,338 107,171

Retained earnings at beginning of
year

(834,591

)

(941,762

)

RETAINED EARNINGS AT END OF
YEAR

(763,253

)

(834,591

)

Mercado Medic UK Limited (Registered number: 06448822)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 11,541 938

CURRENT ASSETS
Stocks 29,240 28,983
Debtors 5 67,238 101,571
Cash at bank 27,056 49,776
123,534 180,330
CREDITORS
Amounts falling due within one year 6 343,080 402,764
NET CURRENT LIABILITIES (219,546 ) (222,434 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(208,005

)

(221,496

)

CREDITORS
Amounts falling due after more than
one year

7

545,248

603,095
NET LIABILITIES (753,253 ) (824,591 )

CAPITAL AND RESERVES
Called up share capital 10,000 10,000
Retained earnings (763,253 ) (834,591 )
(753,253 ) (824,591 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Mercado Medic UK Limited (Registered number: 06448822)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 29 February 2024 and were signed by:





S Van Bloemendaal - Director


Mercado Medic UK Limited (Registered number: 06448822)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Mercado Medic UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts have been prepared on a going concern basis, which assumes that the company will continue to trade for at least one year from the date of approval of these financial statements by the director and thereafter for the foreseeable future. The director considers it appropriate to prepare the financial statements on this basis since the company's ultimate parent undertaking, Bloeman Invest AB, will provide sufficient funds to enable the company to meet its day to day working capital requirements. The financial statements do not include any adjustments that would result from a withdrawal of the support provided by the ultimate parent undertaking.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Mercado Medic UK Limited (Registered number: 06448822)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - 2 ).

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023 12,280
Additions 11,990
At 31 December 2023 24,270
DEPRECIATION
At 1 January 2023 11,342
Charge for year 1,387
At 31 December 2023 12,729
NET BOOK VALUE
At 31 December 2023 11,541
At 31 December 2022 938

Mercado Medic UK Limited (Registered number: 06448822)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 60,508 100,725
Other debtors 6,730 846
67,238 101,571

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 38,273 29,420
Amounts owed to group undertakings 276,376 327,839
Taxation and social security 13,878 28,492
Other creditors 14,553 17,013
343,080 402,764

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.12.23 31.12.22
£    £   
Amounts owed to group undertakings 545,248 603,095

8. OTHER FINANCIAL COMMITMENTS

The total of future minimum lease payments under non-cancellable operating leases as at 31 December 2022 was £1,152 (2021: £1,152).

9. ULTIMATE CONTROLLING PARTY

Mercado UK Limited is regarded by the director as being the company's immediate undertaking and Bloemen Invest AB is the ultimate parent undertaking.

The company address of Bloemen Invest AB is:
Box 1074
SE-181 22 Lidingö
Stockholm